CN107619668B - Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof - Google Patents

Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof Download PDF

Info

Publication number
CN107619668B
CN107619668B CN201610562803.5A CN201610562803A CN107619668B CN 107619668 B CN107619668 B CN 107619668B CN 201610562803 A CN201610562803 A CN 201610562803A CN 107619668 B CN107619668 B CN 107619668B
Authority
CN
China
Prior art keywords
compound represented
general formula
liquid crystal
crystal composition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610562803.5A
Other languages
Chinese (zh)
Other versions
CN107619668A (en
Inventor
陈卯先
储士红
王杰
田会强
未欣
陈海光
姜天孟
郭云鹏
袁瑾
伍嘉琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Bayi Space LCD Technology Co Ltd
Original Assignee
Beijing Bayi Space LCD Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Bayi Space LCD Technology Co Ltd filed Critical Beijing Bayi Space LCD Technology Co Ltd
Priority to CN201610562803.5A priority Critical patent/CN107619668B/en
Publication of CN107619668A publication Critical patent/CN107619668A/en
Application granted granted Critical
Publication of CN107619668B publication Critical patent/CN107619668B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Liquid Crystal Substances (AREA)

Abstract

The invention relates to a liquid crystal composition containing a polyfluorobiphenyl liquid crystal compound, which comprises at least one compound represented by a general formula I, at least one compound represented by a general formula II and at least one compound represented by a general formula III; wherein, the compound represented by the general formula I has a polyfluoro-substituted tricyclic biphenyl structure and has large negative dielectric anisotropy; the compound in the general formula II is a compound with a two-ring structure, has low rotational viscosity, can effectively reduce the rotational viscosity of the liquid crystal composition, and improves the response time of a liquid crystal display; the compound represented by the general formula III is a liquid crystal compound containing a methoxy bridge bond and a2, 3-difluoro-1, 4 phenyl structure, and has large negative dielectric anisotropy. The liquid crystal composition has low rotational viscosity, can be used for fast response liquid crystal display of various display modes, and can obviously improve the display effect of a liquid crystal display when being used in VA mode displays such as VA, MVA, PVA and PSVA, or IPS and FFS mode displays.

Description

Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof
Technical Field
The invention relates to a liquid crystal composition, in particular to a liquid crystal composition which has negative dielectric anisotropy; more specifically, the liquid crystal composition provided by the invention at least comprises a liquid crystal compound containing trifluorobiphenyl.
Background
Liquid crystals are currently widely used in the field of information display, and have been used in optical communications (s.t.wu, d.k.yang.reflective Liquid Crystal display. wiley, 2001). In recent years, the application fields of liquid crystal compounds have been remarkably widened to various display devices, electro-optical devices, electronic components, sensors, and the like, and nematic liquid crystal compounds have been most widely used in flat panel displays, particularly in systems of TFT active matrix.
At present, the negative liquid crystal is widely used in a large-size liquid crystal display for a television, and particularly, the appearance of the PSVA technology makes the negative liquid crystal more popular; in recent years, a negative liquid crystal FFS display is widely used for a display of a mobile device such as a mobile phone, and because of its high transmittance, it can greatly reduce energy consumed by a backlight of the liquid crystal display, improve display quality of the liquid crystal display, and prolong a cruising time of the mobile device.
Negative liquid crystals, which were proposed at the beginning of the 80's last century, are mainly used in VA mode, and have major advantages in high contrast and major disadvantages in small viewing angle and slow response time. With the development of display technology, MVA, PVA, PSVA, and the like technologies have appeared in succession, solving the problems of response time and viewing angle. In recent years, as touch panels become mainstream in the market of mobile devices, IPS and FFS type hard-screen displays have inherent advantages, and both IPS and FFS type displays can use positive liquid crystals and negative liquid crystals, and the positive liquid crystals are aligned along the direction of electric field lines due to the bending electric field existing in the displays, thereby causing bending of molecules and lowering of transmittance; the negative liquid crystal is arranged perpendicular to the direction of the electric field lines, so that the transmittance is greatly improved, and the method is the best method for improving the transmittance and reducing the backlight power consumption at present. However, the response time problem of negative liquid crystals is a significant problem that is currently encountered, and FFS displays using negative liquid crystals have a response time that is 50% or more slower than FFS displays using positive liquid crystals. Therefore, how to increase the response time of the negative liquid crystal is a key issue at present.
Specifically, the response time of the LCD depends on (gamma 1d ^2)/Keff (d is the thickness of the liquid crystal layer, gamma 1 is the liquid crystal rotational viscosity, and Keff is the effective elastic constant), therefore, the purposes of improving the response time can be achieved by reducing the rotational viscosity, reducing the thickness of the liquid crystal layer and improving the elastic constant, and the thickness of the liquid crystal layer depends on the design of the LCD; for liquid crystal compositions, it is most effective to reduce the rotational viscosity and the liquid crystal thickness.
At present, there is a need to develop a liquid crystal composition having a low rotational viscosity that can effectively reduce the response time of a liquid crystal display.
Disclosure of Invention
The invention provides a liquid crystal composition containing a polyfluorobiphenyl liquid crystal compound, which comprises at least one compound represented by a general formula I, at least one compound represented by a general formula II and at least one compound represented by a general formula III.
The compound represented by the general formula I has a polyfluoro-substituted tricyclic biphenyl structure, and the compound has large negative dielectric anisotropy. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula I in the composition is preferably 1-45%, more preferably 3-35%, 5-30%, 3-16%, 5-16%, 16-35%, 16-30%, 3-30%, 5-26%, 5-35%, 10-30%, 5-30%, 10-26%, 10-35%, 14-30% or 10-24%. The general formula I is specifically as follows:
Figure BDA0001051058000000011
in the general formula I, R1、R2Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is1Represents H or F; z1Represents a single bond, CH2O or CH2CH2(ii) a Ring A1Represents trans-1, 4-cyclohexyl or 1, 4-cyclohexene.
Preferably, the compound represented by formula I is selected from one or more of formula IA through formula IF:
Figure BDA0001051058000000021
in IA to IF, R1Represents C2~C7A linear alkyl or linear alkenyl group of (a); r2Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
More preferably, the compound represented by formula I is selected from one or more of formulae IA1 to IF 36:
Figure BDA0001051058000000022
Figure BDA0001051058000000031
Figure BDA0001051058000000041
Figure BDA0001051058000000051
Figure BDA0001051058000000071
further preferably, the compound of formula I is one or more of formulae IA13, IA14, IA15, IA16, IA19, IA20, IA21, IA22, IA25, IA26, IA31, IA32, IB14, IB19, IB20, IB26, IB32, IC14, IC19, IC20, IC26, IC32, ID14, ID20, IE13, IE14, IE19, IE20, IF14, IF 20.
The compound of the general formula II provided by the invention is a compound with a two-ring structure, and the structure has low rotational viscosity, so that the rotational viscosity of the liquid crystal composition can be effectively reduced, and the response time of a liquid crystal display is prolonged. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula II in the composition is preferably 1-75%, more preferably 10-70%, 19-66%, 25-70%, 27-66%, 15-70%, 33-66%, 15-34%, 19-34%, 31-66%, 15-54%, 19-49%, 20-70%, 27-66%, 27-60%, 25-60% or 32-55%. The general formula II is specifically:
in the general formula II, R3、R4Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); ring A2Ring A3Each independently represents trans-1, 4-cyclohexyl or 1, 4-phenylene.
Preferably, the compound of formula II is selected from one or more of formulae IIA to IIC:
Figure BDA0001051058000000073
in the IIA to IIC, R3Represents C1~C7Straight chain alkyl or C2~C7A linear alkenyl group of (a); r4Represents C1~C7Linear alkyl, linear alkoxy or C2~C7Linear alkenyl groups of (a).
More preferably, the compound of formula II is selected from one or more of formula IIA1 to formula IIC 24:
Figure BDA0001051058000000074
Figure BDA0001051058000000081
further preferably, the compound of formula II is selected from one or more of formulae IIA2, IIA6, IIA14, IIA18, IIA22, IIA23, IIA28, IIB10, IIB14, IIC2, IIC4, IIC15, IIC 20.
The compound represented by the general formula III is a liquid crystal compound containing a methoxy bridge bond and a2, 3-difluoro-1, 4 phenyl structure, and the compound has larger negative dielectric anisotropy. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula III in the composition is preferably 1-70%, more preferably 3-60%, 5-57%, 5-55%, 10-52%, 3-55%, 5-50%, 20-60%, 25-57%, 3-34%, 5-34%, 35-60%, 35-57%, 3-57%, 5-52%, 3-60%, 5-60%, 10-57%, 3-50%, 5-45%, 3-45%, 5-39%, 10-60% or 14-57%. The general formula III is specifically:
Figure BDA0001051058000000092
in the general formula III, R5、R6Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); n is 0 or 1.
Preferably, the compound of formula III is selected from one or more of formulae IIIA to IIIB:
Figure BDA0001051058000000093
in IIIA-IIIB, R5Represents C2~C7A linear alkyl or linear alkenyl group of (a); r6Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
More preferably, the compound of formula III is selected from one or more of formulae IIIA1 to IIIE 36:
Figure BDA0001051058000000094
Figure BDA0001051058000000101
Figure BDA0001051058000000111
further preferably, the compound represented by the general formula III is selected from one or more of IIIA14, IIIA17, IIIA19, IIIA20, IIIA21, IIIA22, IIIA23, IIIA26, IIIA32, IIIB13, IIIB14, IIIB15, IIIB16, IIIB17, IIIB18, IIIB19, IIIB20, IIIB21, IIIB22, IIIB23, IIIB24, IIIB29, IIIB 35.
The liquid crystal compound provided by the invention can also comprise one or more compounds shown in the general formula IV. The compound of the general formula IV is a tricyclic neutral compound, and the structure has lower rotational viscosity and higher clearing point. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula IV in the composition is preferably 0-50%, more preferably 0-40%, 0-35%, 0-30%, 0-20%, 0-16%, 0-15%, 0-11% or 0-10%, and further preferably 1-35%, 3-30% or 5-30%. The general formula IV is specifically:
Figure BDA0001051058000000112
in the general formula IV, R7、R8Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); ring A5Represents trans-1, 4-cyclohexyl or 1, 4-phenylene.
Preferably, the compound represented by formula IV is selected from one or more of formulae IVA to IVB:
Figure BDA0001051058000000113
in the above-mentioned IVA to IVB, R7Represents C2~C7Linear alkyl or linear alkenyl of R8Represents C1~C7Linear alkyl or linear alkenyl of (1).
More preferably, the compound of formula IV is selected from one or more of IVA 1-IVB 24:
Figure BDA0001051058000000114
Figure BDA0001051058000000121
further preferably, the compound of formula IV is selected from one or more of formulae IVA2, IVA6, IVA10, IVA13, IVA16, IVB2, IVB6, IVB8, IVB15, IVB 17.
The liquid crystal composition provided by the invention can also comprise one or more compounds represented by the general formula V. The compound represented by the general formula V is a terphenyl compound containing a2, 3-difluorobenzene structure, and the compound has large optical anisotropy and large negative dielectric anisotropy. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula V in the composition is preferably 0-30%, more preferably 0-15%, 0-12%, 0-10% or 0-9%, and further preferably 1-15% or 4-12%. The general formula V is specifically:
Figure BDA0001051058000000122
in the general formula V, R9、R10Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is2Represents H or F.
Preferably, the compound of formula V is selected from one or more of VA and VB:
Figure BDA0001051058000000131
in VA and VB, R9Represents C2~C7A linear alkyl or linear alkenyl group of (a); r10Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
More preferably, the compound represented by formula V is selected from one or more of formulae VA1 to formula VB 24:
Figure BDA0001051058000000132
further preferably, the compound represented by formula V is selected from one or more of formulae VA2, VA9, VA10, VA14, VA16, VA22, VB9, VB10, VB14, VB 22.
The liquid crystal composition provided by the invention can also comprise one or more compounds represented by the general formula VI. In the liquid crystal composition provided by the invention, the sum of all liquid crystal components is 100%; the content of the compound of the general formula VI in the composition is preferably 0-40%, more preferably 0-30%, 0-25%, 0-23%, 0-20%, 0-15%, 0-14%, 0-11%, 0-10%, and further preferably 1-25% or 7-23%. The general formula VI is in particular:
Figure BDA0001051058000000142
in the general formula VI, R11、R12Each independently represent F, C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is3、L4、L5Each independently represents H or F.
Preferably, the compound represented by formula VI is selected from one or more of formula VIA to formula VIC:
Figure BDA0001051058000000143
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
More preferably, the compound represented by formula VI is selected from one or more of the formulae VIA 1-VIC 6:
Figure BDA0001051058000000144
further preferably, the compound represented by formula VI is selected from one or more of formulae VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8, and VIC 2.
In order to enable the liquid crystal composition to meet different requirements, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 1-45% of a compound represented by the general formula I;
(2) 1-75% of a compound represented by the general formula II;
(3) 1 to 70% of a compound represented by the general formula III;
(4) 0 to 50% of a compound represented by the general formula IV;
(5) 0 to 30% of a compound represented by the general formula V;
(6) 0-40% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-35% of a compound represented by the general formula I;
(2) 10-70% of a compound represented by the general formula II;
(3) 3-60% of a compound represented by the general formula III;
(4) 0 to 40% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-16% of a compound represented by the general formula I;
(2) 25-70% of a compound represented by the general formula II;
(3) 5-55% of a compound represented by the general formula III;
(4) 0 to 40% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-16% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 10-52% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 16-35% of a compound represented by the general formula I;
(2) 15-70% of a compound represented by the general formula II;
(3) 3-60% of a compound represented by the general formula III;
(4) 0 to 20% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 16-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-30% of a compound represented by the general formula I;
(2) 33-70% of a compound represented by the general formula II;
(3) 3-55% of a compound represented by the general formula III;
(4) 0 to 35% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-26% of a compound represented by the general formula I;
(2) 33-66% of a compound represented by the general formula II;
(3) 5 to 50% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 10% of a compound represented by the general formula V;
(6) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-35% of a compound represented by the general formula I;
(2) 15-34% of a compound represented by the general formula II;
(3) 20-60% of a compound represented by the general formula III;
(4) 0 to 20% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 20% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 10-30% of a compound represented by the general formula I;
(2) 19 to 34% of a compound represented by the general formula II;
(3) 25-57% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 14% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 25-70% of a compound represented by the general formula II;
(3) 3-34% of a compound represented by the general formula III;
(4) 0 to 35% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 25% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 10-26% of a compound represented by the general formula I;
(2) 31-66% of a compound represented by the general formula II;
(3) 5-34% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 9% of a compound represented by the general formula V;
(6) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-35% of a compound represented by the general formula I;
(2) 15-54% of a compound represented by the general formula II;
(3) 35-60% of a compound represented by the general formula III;
(4) 0 to 20% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 20% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 19-49% of a compound represented by the general formula II;
(3) 35-57% of a compound represented by the general formula III;
(4) 0 to 11% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 10% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-30% of a compound represented by the general formula I;
(2) 20-70% of a compound represented by the general formula II;
(3) 3-57% of a compound represented by the general formula III;
(4) 1-35% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) 0 to 20% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-26% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 5-52% of a compound represented by the general formula III;
(4) 3-30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0-15% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-35% of a compound represented by the general formula I;
(2) 15-70% of a compound represented by the general formula II;
(3) 3-60% of a compound represented by the general formula III;
(4) 0 to 15% of a compound represented by the general formula V;
(5) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 10-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 10% of a compound represented by the general formula V;
(5) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-35% of a compound represented by the general formula I;
(2) 15-70% of a compound represented by the general formula II;
(3) 5-60% of a compound represented by the general formula III;
(4) 0 to 35% of a compound represented by the general formula IV;
(5) 0 to 30% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 10-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) and 0-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-30% of a compound represented by the general formula I;
(2) 20-70% of a compound represented by the general formula II;
(3) 3 to 50% of a compound represented by the general formula III;
(4) 0 to 20% of a compound represented by the general formula IV;
(5) 1-15% of a compound represented by the general formula V;
(6) 0-15% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-26% of a compound represented by the general formula I;
(2) 27 to 60% of a compound represented by the general formula II;
(3) 5-45% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 4-12% of a compound represented by the general formula V;
(6) 0-11% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-30% of a compound represented by the general formula I;
(2) 25-60% of a compound represented by the general formula II;
(3) 3-45% of a compound represented by the general formula III;
(4) 0 to 15% of a compound represented by the general formula IV;
(5) 0 to 15% of a compound represented by the general formula V;
(6) and 1-25% of a compound represented by the general formula VI.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-26% of a compound represented by the general formula I;
(2) 32-55% of a compound represented by the general formula II;
(3) 5-39% of a compound represented by the general formula III;
(4) 0 to 10% of a compound represented by the general formula IV;
(5) 0 to 9% of a compound represented by the general formula V;
(6) and 7-23% of a compound represented by the general formula VI.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 3-35% of a compound represented by the general formula I;
(2) 15-70% of a compound represented by the general formula II;
(3) 3-60% of a compound represented by the general formula III;
(4) 0 to 35% of a compound represented by the general formula IV;
(5) 0-15% of a compound represented by the general formula V.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0-12% of a compound represented by the general formula V.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 10-35% of a compound represented by the general formula I;
(2) 15-70% of a compound represented by the general formula II;
(3) 10-60% of a compound represented by the general formula III.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 14-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 14-57% of a compound represented by the general formula III.
Preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 25-70% of a compound represented by the general formula II;
(3) 5-55% of a compound represented by the general formula III;
(4) and 3-35% of a compound represented by the general formula IV.
More preferably, the liquid crystal composition provided by the invention comprises the following components in percentage by mass:
(1) 10-24% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 10-52% of a compound represented by the general formula III;
(4) and 5-30% of a compound represented by the general formula IV.
The method for producing the liquid crystal composition of the present invention is not particularly limited, and it can be produced by mixing two or more compounds by a conventional method, such as a method of mixing the different components at a high temperature and dissolving each other, wherein the liquid crystal composition is dissolved and mixed in a solvent for the compounds, and then the solvent is distilled off under reduced pressure; alternatively, the liquid crystal composition of the present invention can be prepared by a conventional method, for example, by dissolving the component having a smaller content in the main component having a larger content at a higher temperature, or by dissolving each of the components in an organic solvent, for example, acetone, chloroform or methanol, and then mixing the solutions to remove the solvent.
The liquid crystal composition has low rotational viscosity, can be used for fast response liquid crystal display of various display modes, and can obviously improve the display effect of a liquid crystal display when being used in VA mode displays such as VA, MVA, PVA and PSVA, or IPS and FFS mode displays.
The liquid crystal composition provided by the invention can further comprise one or more polymerizable compounds shown as a general formula VII. The general formula VII is specifically as follows:
Figure BDA0001051058000000201
in the general formula VII, m represents 0 or 1; SP1、SP2Each independently represents a polymerizable group; l is6Represents H or F; l is7Representative H, F, C1~C5Linear alkyl or linear alkoxy groups of (1).
Preferably, the polymerizable compound represented by formula VII is selected from one or more of formulas VIIA to VIIF:
Figure BDA0001051058000000202
Figure BDA0001051058000000211
among the VIIA to VIIF, SP1、SP2Each independently represents an acrylate group, a methacrylate group, a butenoate group or a linear alkenyl group of C2-C8.
More preferably, the polymerizable compound represented by formula VII is selected from one or more of the large groups represented by formulas VIIA1 to VIIF 3:
Figure BDA0001051058000000212
Figure BDA0001051058000000221
further preferably, the polymerizable compound represented by general formula VII is selected from one or more of formulas VIIA2, VIIB2, VIIC2, VIID2, VIIE2, VIIF 2.
The amount of the polymerizable compound with the general formula VII is 0.1-5% of the total weight of other liquid crystal compounds in the liquid crystal composition; the preferable dosage is 0.2-1.0% of the weight of other liquid crystal compounds in the liquid crystal composition; more preferably, the amount is 0.3 to 0.5% by weight of the other liquid crystal compounds in the liquid crystal composition. The liquid crystal composition containing the polymerizable compound provided by the invention is used for a PSVA liquid crystal display.
The preparation method of the liquid crystal composition containing the polymerizable compound provided by the invention comprises the steps of pouring the liquid crystal composition containing the polymerizable compound into a liquid crystal screen, irradiating and polymerizing through UV light, and continuously applying voltage in the irradiation process. The polymerizable compounds in the liquid crystal composition polymerize under the irradiation of UV light, and a network-like structure is generated.
Detailed Description
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention.
In the present invention, the percentages are by weight, the temperatures are given in degrees Celsius, △ n represents the optical anisotropy (25 ℃), εAnd εRespectively representing the parallel and perpendicular dielectric constants (25 ℃, 1000Hz), △ epsilon representing the dielectric anisotropy (25 ℃, 1000Hz), gamma 1 representing the rotational viscosity (mPa. s, 25 ℃), Cp representing the clearing point (. degree. C.) of the liquid crystal composition, K11、K22、K33Respectively representing the splay, twist and bend elastic constants (pN, 25 ℃).
In the following examples, the group structures in the liquid crystal compounds are represented by codes shown in Table 1.
Table 1: radical structure code of liquid crystal compound
Figure BDA0001051058000000222
Figure BDA0001051058000000231
Take the following compound structure as an example:
Figure BDA0001051058000000232
expressed as: 3CGIWO4
Figure BDA0001051058000000233
Expressed as: 3CC1OWO2
In the following examples, the liquid crystal composition was prepared by a thermal dissolution method, comprising the steps of: weighing the liquid crystal compound by a balance according to the weight percentage, wherein the weighing and adding sequence has no specific requirements, generally weighing and mixing the liquid crystal compound in sequence from high melting point to low melting point, heating and stirring at 60-100 ℃ to uniformly melt all the components, filtering, performing rotary evaporation, and finally packaging to obtain the target sample.
In the following examples, the weight percentages of the components in the liquid crystal composition and the performance parameters of the liquid crystal composition are shown in the following tables.
Example 1
Table 2: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 2
Table 3: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000242
Example 3
Table 4: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000243
Example 4
Table 5: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000244
Figure BDA0001051058000000251
Example 5
Table 6: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000252
Example 6
Table 7: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 7
Table 8: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000254
Example 8
Table 9: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000262
Example 9
Table 10: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000263
Example 10
Table 11: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000264
Figure BDA0001051058000000271
Example 11
Table 12: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000272
Example 12
Table 13: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000273
Example 13
Table 14: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 14
Table 15: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000282
Example 15
Table 16: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000283
Example 16
Table 17: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000291
Example 17
Table 18: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000292
Example 18
Table 19: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000293
Figure BDA0001051058000000301
Example 19
Table 20: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000302
Example 20
Table 21: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000303
Example 21
Table 22: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000304
Example 22
Table 23: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000311
Example 23
Table 24: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000312
Example 24
Table 25: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 25
Table 26: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000321
Example 26
Table 27: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000322
Example 27
Table 28: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000323
Figure BDA0001051058000000331
Example 28
Table 29: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000332
Example 29
Table 30: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000333
Example 30
Table 31: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000334
Example 31
Table 32: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000341
Example 32
Table 33: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 33
Table 34: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 34
Table 35: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 35
Table 36: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000352
Example 36
Table 37: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000353
Example 37
Table 38: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000361
Example 38
Table 39: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000362
Example 39
Table 40: the weight percentage and performance parameters of each component in the liquid crystal composition
Example 40
Table 41: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000371
Comparative example 1
Table 42: the weight percentage and performance parameters of each component in the liquid crystal composition
Figure BDA0001051058000000372
The liquid crystal compositions obtained in example 1 and comparative example 1 were compared in summary with respect to the values of the respective performance parameters, see Table 43.
Table 43: comparison of Performance parameters of liquid Crystal compositions
Δn △ε Cp γ1 K11 K22 K33
Example 1 0.108 -3.8 90 83 14.8 7.4 16.3
Comparative example 1 0.108 -3.8 90 96 14.7 7.4 16.5
By comparison, it can be seen that: example 1 provides a liquid crystal composition having a low rotational viscosity, i.e., having a faster response time, compared to comparative example 1.
EXAMPLE 41
A liquid crystal mixture (PA1) for PSVA was prepared by adding 0.3% of polymerizable compound VIIA2 in mass percent to the nematic liquid crystal composition (N1) provided in example 1, and the nematic liquid crystal composition N1 and the PSVA mixture PA1 were charged into a standard VA test cell, and irradiated with UV (100mw/cm2) for two minutes under a voltage of 10V applied, and the pretilt angle, threshold voltage, and response time were measured, respectively. The test results are shown in Table 44:
table 44: threshold voltage and response time test results
Figure BDA0001051058000000373
Figure BDA0001051058000000381
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
Example 42
A liquid crystal mixture (PA4) for PSVA was prepared by adding 0.3% of polymerizable compound VIIA2 in mass percent to the nematic liquid crystal composition (N4) provided in example 4, and the nematic liquid crystal composition N4 and the PSVA mixture PA4 were charged into a standard VA test cell, and irradiated with UV (100mw/cm2) for two minutes under a voltage of 10V applied, and the pretilt angle, threshold voltage, and response time were measured, respectively. The test results are shown in table 45:
table 45: threshold voltage and response time test results
Item titl(°) V10(V) T(ms)
N4 89.3 2.34 14.5
PA4 82.1 1.90 5.4
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
Example 43
A liquid crystal mixture (PB30) for PSVA was prepared by adding 0.4% of polymerizable compound VIIB2 in mass percent to the nematic liquid crystal composition (N30) provided in example 30, and the nematic liquid crystal composition N30 and PSVA mixture PB30 were charged into a standard VA test cell, and irradiated with UV (100mw/cm2) for two minutes under a voltage of 10V applied, and the pretilt angle, threshold voltage, and response time were measured, respectively. The test results are shown in table 46:
table 46: threshold voltage and response time test results
Item titl(°) V10(V) T(ms)
N30 89.8 2.31 15.6
PB30 81.6 1.89 5.9
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
Example 44
A liquid crystal mixture for PSVA (PD33) was prepared by adding 0.5% by mass of the polymerizable compound VIID2 to the nematic liquid crystal composition (N33) provided in example 33, and the nematic liquid crystal composition N33 and the PSVA mixture PD33 were charged into a standard VA test cell, and irradiated with UV (100mw/cm2) for two minutes under application of a voltage of 10V, and the pretilt angle, the threshold voltage, and the response time were measured, respectively. The test results are shown in Table 47:
table 47: threshold voltage and response time test results
Item titl(°) V10(V) T(ms)
N33 89.7 2.39 16.0
PD33 81.1 2.03 6.1
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
Example 45
A liquid crystal mixture for PSVA (PC34) was prepared by adding 0.4% of polymerizable compound VIIC2 in mass percent to the nematic liquid crystal composition (N34) provided in example 34, and the nematic liquid crystal composition N34 and the PSVA mixture PC34 were charged into a standard VA test cell, and irradiated with UV (100mw/cm2) for two minutes under a voltage of 10V applied, and the pretilt angle, threshold voltage, and response time were measured, respectively. The test results are shown in Table 48:
table 48: threshold voltage and response time test results
Item titl(°) V10(V) T(ms)
N34 89.4 2.43 14.8
PC34 81.0 2.06 5.3
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
Example 46
A liquid crystal mixture (PF36) for PSVA was prepared by adding 0.3% of polymerizable compound VIIF2 in mass percent to the nematic liquid crystal composition (N36) provided in example 36, and the nematic liquid crystal composition N36 and the PSVA mixture PF36 were charged into a standard VA test cell and irradiated with UV (100mw/cm2) for two minutes under a voltage of 10V applied to test the pretilt angle, threshold voltage and response time, respectively. The test results are shown in Table 49:
table 49: threshold voltage and response time test results
Item titl(°) V10(V) T(ms)
N36 89.4 2.70 14.3
PF36 81.4 2.35 4.7
Compared with the corresponding liquid crystal composition, the liquid crystal composition with the polymerizable compound has the advantages that the threshold voltage is reduced after polymerization, the response time is accelerated, and the response time of the liquid crystal display is obviously prolonged.
The liquid crystal composition provided by the invention is mixed with a polymerizable compound and then used for a PSVA liquid crystal display, so that the response time of the liquid crystal display can be effectively prolonged, and the display effect of the liquid crystal display is obviously improved.
The negative dielectric anisotropy liquid crystal composition provided by the invention has low rotational viscosity, high resistivity and excellent light stability and thermal stability, is suitable for VA type liquid crystal displays such as VA, MVA, PVA and PSVA, or IPS and FFS type liquid crystal displays, and can effectively improve the response time of the liquid crystal display.
Although the invention has been described in detail hereinabove with respect to a general description and specific embodiments thereof, it will be apparent to those skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.

Claims (64)

1. The liquid crystal composition containing the polyfluorobiphenyl liquid crystal compound is characterized by comprising the following components in percentage by mass:
(1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 23% of a compound represented by the general formula VI;
the general formula I is specifically as follows:
Figure FDA0002250388650000011
in the general formula I, R1、R2Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is1Represents H or F; z1Represents a single bond; ring A1Represents trans-1, 4-cyclohexyl or 1, 4-cyclohexene;
the general formula II is specifically:
in the general formula II, R3、R4Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); ring A2Ring A3Each independently represents trans-1, 4-cyclohexyl or 1, 4-phenylene;
the general formula III is specifically:
Figure FDA0002250388650000013
in the general formula III, R5、R6Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); n is 0 or 1;
the general formula IV is specifically:
Figure FDA0002250388650000014
in the general formula IV, R7、R8Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); ring A5Represents trans-1, 4-cyclohexyl or 1, 4-phenylene;
the general formula V is specifically:
Figure FDA0002250388650000015
in the general formula V, R9、R10Each independently represents C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is2Represents H or F;
in the general formula VI, R11、R12Each independently represent F, C1~C12Linear alkyl, linear alkoxy or C2~C12A linear alkenyl group of (a); l is3、L4、L5Each independently represents H or F.
2. The liquid crystal composition of claim 1, wherein the compound represented by formula I is selected from one or more of formula IA to formula ID:
Figure FDA0002250388650000021
in IA to ID, R1Represents C2~C7A linear alkyl or linear alkenyl group of (a); r2Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
3. The liquid crystal composition of claim 2, wherein the compound represented by formula I is selected from one or more of formulae IA1 to ID 36:
Figure FDA0002250388650000022
Figure FDA0002250388650000031
Figure FDA0002250388650000041
Figure FDA0002250388650000051
4. liquid crystal composition according to claim 3, characterized in that, more preferably, the compound of formula I is one or more of the formulae IA13, IA14, IA15, IA16, IA19, IA20, IA21, IA22, IA25, IA26, IA31, IA32, IB14, IB19, IB20, IB26, IB32, IC14, IC19, IC20, IC26, IC32, ID14, ID 20.
5. Liquid crystal composition according to any of claims 1 to 4, wherein the compound of formula II is selected from one or more of formulae IIA to IIC:
in the IIA to IIC, R3Represents C1~C7Straight chain alkyl or C2~C7A linear alkenyl group of (a); r4Represents C1~C7Linear alkyl, linear alkoxy or C2~C7Linear alkenyl groups of (a).
6. The liquid crystal composition of claim 5, wherein the compound of formula II is selected from one or more of formula IIA1 to formula IIC 24:
Figure FDA0002250388650000053
Figure FDA0002250388650000061
Figure FDA0002250388650000071
7. liquid crystal composition according to claim 6, characterized in that the compound of formula II is selected from one or more of the group consisting of the compounds of formulae IIA2, IIA6, IIA14, IIA18, IIA22, IIA23, IIA28, IIB10, IIB14, IIC2, IIC4, IIC15, IIC 20.
8. The liquid crystal composition of any one of claims 1 to 4, 6 and 7, wherein the compound of formula III is selected from one or more of formulae IIIA to IIIB:
Figure FDA0002250388650000072
in IIIA-IIIB, R5Represents C2~C7A linear alkyl or linear alkenyl group of (a); r6Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
9. The liquid crystal composition of claim 8, wherein the compound of formula III is selected from one or more of formulae IIIA 1-IIIB 36:
Figure FDA0002250388650000073
Figure FDA0002250388650000081
Figure FDA0002250388650000091
10. the liquid crystal composition of claim 9, wherein the compound represented by formula III is selected from one or more of IIIA14, IIIA17, IIIA19, IIIA20, IIIA21, IIIA22, IIIA23, IIIA26, IIIA32, IIIB13, IIIB14, IIIB15, IIIB16, IIIB17, IIIB18, IIIB19, IIIB20, IIIB21, IIIB22, IIIB23, IIIB24, IIIB29, and IIIB 35.
11. The liquid crystal composition of claim 5, wherein the compound of formula III is selected from one or more of formulae IIIA to IIIB:
Figure FDA0002250388650000092
in IIIA-IIIB, R5Represents C2~C7A linear alkyl or linear alkenyl group of (a); r6Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
12. The liquid crystal composition of claim 11, wherein the compound of formula III is selected from one or more of formulae IIIA 1-IIIB 36:
Figure FDA0002250388650000093
Figure FDA0002250388650000101
Figure FDA0002250388650000111
13. the liquid crystal composition of claim 12, wherein the compound represented by formula III is selected from one or more of IIIA14, IIIA17, IIIA19, IIIA20, IIIA21, IIIA22, IIIA23, IIIA26, IIIA32, IIIB13, IIIB14, IIIB15, IIIB16, IIIB17, IIIB18, IIIB19, IIIB20, IIIB21, IIIB22, IIIB23, IIIB24, IIIB29, and IIIB 35.
14. The liquid crystal composition according to any one of claims 1 to 4, 6, 7 and 9 to 13, wherein the compound represented by the general formula IV is selected from one or more compounds represented by the formulas IVA to IVB:
Figure FDA0002250388650000112
in the above-mentioned IVA to IVB, R7Represents C2~C7Linear alkyl or linear alkenyl of R8Represents C1~C7Linear alkyl or linear alkenyl of (1).
15. The liquid crystal composition of claim 14, wherein the compound of formula IV is selected from one or more of IVA 1-IVB 20:
Figure FDA0002250388650000121
16. liquid crystal composition according to claim 15, wherein the compound of formula IV is selected from one or more of the formulae IVA2, IVA6, IVA10, IVA13, IVA16, IVB2, IVB6, IVB8, IVB15, IVB 17.
17. The liquid crystal composition of claim 5, wherein the compound represented by formula IV is selected from one or more of formulae IVA to IVB:
Figure FDA0002250388650000122
in the above-mentioned IVA to IVB, R7Represents C2~C7Linear alkyl or linear alkenyl of R8Represents C1~C7Linear alkyl or linear alkenyl of (1).
18. The liquid crystal composition of claim 17, wherein the compound of formula IV is selected from one or more of IVA 1-IVB 20:
Figure FDA0002250388650000131
19. liquid crystal composition according to claim 18, wherein the compound of formula IV is selected from one or more of the formulae IVA2, IVA6, IVA10, IVA13, IVA16, IVB2, IVB6, IVB8, IVB15, IVB 17.
20. The liquid crystal composition of claim 8, wherein the compound represented by formula IV is selected from one or more of formulae IVA to IVB:
Figure FDA0002250388650000132
in the above-mentioned IVA to IVB, R7Represents C2~C7Linear alkyl or linear alkenyl of R8Represents C1~C7Linear alkyl or linear alkenyl of (1).
21. The liquid crystal composition of claim 20, wherein the compound of formula IV is selected from one or more of IVA 1-IVB 20:
22. liquid crystal composition according to claim 21, wherein the compound of formula IV is selected from one or more of the formulae IVA2, IVA6, IVA10, IVA13, IVA16, IVB2, IVB6, IVB8, IVB15, IVB 17.
23. Liquid crystal composition according to any of claims 1-4, 6, 7, 9-13, 15-22, wherein the compound of general formula V is selected from one or more of VA and VB:
Figure FDA0002250388650000151
in VA and VB, R9Represents C2~C7A linear alkyl or linear alkenyl group of (a); r10Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
24. The liquid crystal composition of claim 23, wherein the compound represented by formula V is one or more compounds selected from the group consisting of formula VA1 to formula VB 24:
Figure FDA0002250388650000152
Figure FDA0002250388650000161
25. the liquid crystal composition of claim 24, wherein the compound represented by formula V is selected from one or more of formulae VA2, VA9, VA10, VA14, VA16, VA22, VB9, VB10, VB14, and VB 22.
26. Liquid crystal composition according to claim 5, characterized in that the compound of formula V is selected from one or more of VA and VB:
Figure FDA0002250388650000162
in VA and VB, R9Represents C2~C7A linear alkyl or linear alkenyl group of (a); r10Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
27. The liquid crystal composition of claim 26, wherein the compound represented by formula V is selected from one or more of formulae VA1 to VB 24:
Figure FDA0002250388650000171
28. the liquid crystal composition of claim 27, wherein the compound represented by formula V is selected from one or more of formulae VA2, VA9, VA10, VA14, VA16, VA22, VB9, VB10, VB14, and VB 22.
29. Liquid crystal composition according to claim 8, characterized in that the compound of general formula V is selected from one or more of VA and VB:
Figure FDA0002250388650000172
in VA and VB, R9Represents C2~C7A linear alkyl or linear alkenyl group of (a); r10Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
30. The liquid crystal composition of claim 29, wherein the compound represented by formula V is one or more compounds selected from the group consisting of formula VA1 to formula VB 24:
Figure FDA0002250388650000173
31. the liquid crystal composition of claim 30, wherein the compound represented by formula V is selected from one or more of formulae VA2, VA9, VA10, VA14, VA16, VA22, VB9, VB10, VB14, and VB 22.
32. Liquid crystal composition according to claim 14, wherein the compound of formula V is selected from one or more of VA and VB:
Figure FDA0002250388650000191
in VA and VB, R9Represents C2~C7A linear alkyl or linear alkenyl group of (a); r10Represents C1~C7Linear alkyl or linear alkoxy groups of (1).
33. The liquid crystal composition of claim 32, wherein the compound represented by formula V is one or more selected from the group consisting of formula VA1 to formula VB 24:
Figure FDA0002250388650000192
Figure FDA0002250388650000201
34. the liquid crystal composition of claim 33, wherein the compound represented by formula V is selected from one or more of formulae VA2, VA9, VA10, VA14, VA16, VA22, VB9, VB10, VB14, and VB 22.
35. The liquid crystal composition of any one of claims 1 to 4, 6, 7, 9 to 13, 15 to 22, and 24 to 34, wherein the compound represented by formula VI is selected from one or more of formulae VIA to VIC:
Figure FDA0002250388650000202
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
36. The liquid crystal composition of claim 35, wherein the compound represented by formula VI is selected from one or more of formulae VIA 1-VIC 6:
Figure FDA0002250388650000203
Figure FDA0002250388650000211
37. the liquid crystal composition of claim 36, wherein the compound represented by formula VI is selected from one or more of the group consisting of VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8, and VIC 2.
38. The liquid crystal composition of claim 5, wherein the compound represented by formula VI is selected from one or more of formula VIA to formula VIC:
Figure FDA0002250388650000212
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
39. The liquid crystal composition of claim 38, wherein the compound represented by formula VI is selected from one or more of formulae VIA 1-VIC 6:
Figure FDA0002250388650000213
40. the liquid crystal composition of claim 39, wherein the compound represented by formula VI is selected from one or more of the group consisting of formula VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8, and VIC 2.
41. The liquid crystal composition of claim 8, wherein the compound represented by formula VI is selected from one or more of formulae VIA to VIC:
Figure FDA0002250388650000232
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
42. The liquid crystal composition of claim 41, wherein the compound represented by formula VI is selected from one or more of formulae VIA 1-VIC 6:
Figure FDA0002250388650000233
Figure FDA0002250388650000241
43. the liquid crystal composition of claim 42, wherein the compound represented by formula VI is selected from one or more of the group consisting of formula VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8, and VIC 2.
44. The liquid crystal composition of claim 14, wherein the compound represented by formula VI is selected from one or more of formula VIA to formula VIC:
Figure FDA0002250388650000242
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
45. The liquid crystal composition of claim 44, wherein the compound represented by formula VI is selected from one or more of formulae VIA 1-VIC 6:
Figure FDA0002250388650000243
Figure FDA0002250388650000251
46. the liquid crystal composition of claim 45, wherein the compound represented by formula VI is selected from one or more of the group consisting of VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8 and VIC 2.
47. The liquid crystal composition of claim 23, wherein the compound represented by formula VI is selected from one or more of formula VIA to formula VIC:
Figure FDA0002250388650000261
in the VIA-VIC, R is11、R12Each independently represents C1~C7Straight chain alkyl or C2~C7Linear alkenyl groups of (a).
48. The liquid crystal composition of claim 47, wherein the compound represented by formula VI is selected from one or more of formulas VIA 1-VIC 6:
Figure FDA0002250388650000262
Figure FDA0002250388650000271
49. the liquid crystal composition of claim 48, wherein the compound represented by formula VI is selected from one or more of the group consisting of formula VIA2, VIA3, VIA4, VIA6, VIA8, VIA17, VIA18, VIA19, VIA22, VIA23, VIA24, VIB2, VIB6, VIB7, VIB8, and VIC 2.
50. The liquid crystal composition according to any one of claims 1 to 4, 6, 7, 9 to 13, 15 to 22, 24 to 34, and 36 to 49, wherein the liquid crystal composition comprises the following components in percentage by mass:
(1) 5-16% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 10-52% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 23% of a compound represented by the general formula VI;
or (1) 16-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 23% of a compound represented by the general formula VI;
or (1) 5-26% of a compound represented by the general formula I;
(2) 33-66% of a compound represented by the general formula II;
(3) 5 to 50% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 10% of a compound represented by the general formula V;
(6) 0 to 23% of a compound represented by the general formula VI;
or (1) 10-30% of a compound represented by the general formula I;
(2) 19 to 34% of a compound represented by the general formula II;
(3) 25-57% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 14% of a compound represented by the general formula VI;
or (1) 10-26% of a compound represented by the general formula I;
(2) 31-66% of a compound represented by the general formula II;
(3) 5-34% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 9% of a compound represented by the general formula V;
(6) 0 to 23% of a compound represented by the general formula VI;
or (1) 5-30% of a compound represented by the general formula I;
(2) 19-49% of a compound represented by the general formula II;
(3) 35-57% of a compound represented by the general formula III;
(4) 0 to 11% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 10% of a compound represented by the general formula VI;
or (1) 5-26% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 5-52% of a compound represented by the general formula III;
(4) 3-30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
(6) 0 to 15% of a compound represented by the general formula VI;
or (1) 10-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 10% of a compound represented by the general formula V;
(5) 0 to 23% of a compound represented by the general formula VI;
or (1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 10-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 23% of a compound represented by the general formula VI;
or (1) 5-26% of a compound represented by the general formula I;
(2) 27 to 60% of a compound represented by the general formula II;
(3) 5-45% of a compound represented by the general formula III;
(4) 0 to 16% of a compound represented by the general formula IV;
(5) 4-12% of a compound represented by the general formula V;
(6) 0 to 11% of a compound represented by the general formula VI;
or (1) 5-26% of a compound represented by the general formula I;
(2) 32-55% of a compound represented by the general formula II;
(3) 5-39% of a compound represented by the general formula III;
(4) 0 to 10% of a compound represented by the general formula IV;
(5) 0 to 9% of a compound represented by the general formula V;
(6) 7-23% of a compound represented by the general formula VI;
or (1) 5-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 5-57% of a compound represented by the general formula III;
(4) 0 to 30% of a compound represented by the general formula IV;
(5) 0 to 12% of a compound represented by the general formula V;
or (1) 14-30% of a compound represented by the general formula I;
(2) 19-66% of a compound represented by the general formula II;
(3) 14-57% of a compound represented by the general formula III;
or (1) 10-24% of a compound represented by the general formula I;
(2) 27 to 66% of a compound represented by the general formula II;
(3) 10-52% of a compound represented by the general formula III;
(4) and 5-30% of a compound represented by the general formula IV.
51. The liquid crystal composition of any of claims 1-4, 6, 7, 9-13, 15-22, 24-34, 36-49, further comprising one or more polymerizable compounds represented by formula VII, in particular:
in the general formula VII, m represents 0 or 1; SP1、SP2Each independently represents a polymerizable group; l is6Represents H or F; l is7Representative H, F, C1~C5Straight chain alkyl or C1~C5Linear alkoxy groups of (1).
52. The liquid crystal composition of claim 51, wherein the polymerizable compound represented by formula VII is selected from one or more of formulas VIIA to VIIF:
among the VIIA to VIIF, SP1、SP2Each independently represents an acrylate group, a methacrylate group, a butenoate group or a linear alkenyl group of C2-C8.
53. The liquid crystal composition of claim 52, wherein the polymerizable compound represented by formula VII is selected from one or more compounds of formulas VIIA 1-VIIF 3:
Figure FDA0002250388650000293
Figure FDA0002250388650000301
54. the liquid crystal composition of claim 53, wherein the polymerizable compound represented by formula VII is selected from one or more of formulas VIIA2, VIIB2, VIIC2, VIID2, VIIE2, and VIIF 2.
55. The liquid crystal composition of claim 51, wherein the polymerizable compound is used in an amount of 0.1 to 5% by weight based on the total weight of other liquid crystal compounds in the liquid crystal composition.
56. The liquid crystal composition of claim 55, wherein the polymerizable compound is present in an amount of 0.2 to 1.0% by weight based on the total weight of the other liquid crystal compounds in the liquid crystal composition.
57. The liquid crystal composition of claim 56, wherein the polymerizable compound is present in an amount of 0.3 to 0.5% by weight based on the total weight of the other liquid crystal compounds in the liquid crystal composition.
58. The liquid crystal composition of any one of claims 52 to 54, wherein the polymerizable compound is used in an amount of 0.1 to 5% by weight based on the total weight of the other liquid crystal compounds in the liquid crystal composition.
59. The liquid crystal composition of claim 58, wherein the polymerizable compound is used in an amount of 0.2 to 1.0% by weight based on the total weight of other liquid crystal compounds in the liquid crystal composition.
60. The liquid crystal composition of claim 59, wherein the polymerizable compound is used in an amount of 0.3 to 0.5% by weight based on the total weight of other liquid crystal compounds in the liquid crystal composition.
61. Use of the liquid crystal composition according to any one of claims 1 to 60 in a display device.
62. Use of the liquid crystal composition of any one of claims 1 to 50 in a fast response liquid crystal display.
63. Use of the liquid crystal composition of any one of claims 1 to 50 in a VA mode display or an IPS, FFS mode display.
64. Use of the liquid crystal composition of any of claims 51-60 in a PSVA liquid crystal display.
CN201610562803.5A 2016-07-15 2016-07-15 Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof Active CN107619668B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610562803.5A CN107619668B (en) 2016-07-15 2016-07-15 Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610562803.5A CN107619668B (en) 2016-07-15 2016-07-15 Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof

Publications (2)

Publication Number Publication Date
CN107619668A CN107619668A (en) 2018-01-23
CN107619668B true CN107619668B (en) 2020-02-21

Family

ID=61087978

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610562803.5A Active CN107619668B (en) 2016-07-15 2016-07-15 Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof

Country Status (1)

Country Link
CN (1) CN107619668B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111944541A (en) * 2019-05-16 2020-11-17 北京八亿时空液晶科技股份有限公司 Negative liquid crystal composition with quick response time and application thereof
CN113072956B (en) * 2020-01-03 2023-03-31 北京八亿时空液晶科技股份有限公司 High-contrast negative liquid crystal composition containing phenprobucol and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0969071A1 (en) * 1998-06-02 2000-01-05 Chisso Corporation Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device
JP2011026274A (en) * 2009-07-29 2011-02-10 Dic Corp Difluorobenzene derivative, liquid crystal composition containing the compound and liquid crystal display element
CN102574759A (en) * 2009-10-01 2012-07-11 捷恩智株式会社 Liquid crystalline compound with negative dielectric anisotropy, liquid crystal composition using same, and liquid crystal display element
EP2479162A1 (en) * 2009-09-18 2012-07-25 JNC Corporation Liquid crystalline compound, liquid crystal composition, and liquid crystal display element
EP2631225A1 (en) * 2010-10-21 2013-08-28 JNC Corporation Cyclohexene-3,6-diyl compound, liquid crystal composition, and liquid crystal display element

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5359016B2 (en) * 2008-05-08 2013-12-04 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP5515619B2 (en) * 2009-10-26 2014-06-11 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP6248557B2 (en) * 2012-11-16 2017-12-20 Jnc株式会社 Liquid crystalline compound having vinyloxy, liquid crystal composition, and liquid crystal display device
CN106753422B (en) * 2015-11-19 2021-04-20 江苏和成显示科技有限公司 Liquid crystal composition and display device thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0969071A1 (en) * 1998-06-02 2000-01-05 Chisso Corporation Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device
JP2011026274A (en) * 2009-07-29 2011-02-10 Dic Corp Difluorobenzene derivative, liquid crystal composition containing the compound and liquid crystal display element
EP2479162A1 (en) * 2009-09-18 2012-07-25 JNC Corporation Liquid crystalline compound, liquid crystal composition, and liquid crystal display element
CN102574759A (en) * 2009-10-01 2012-07-11 捷恩智株式会社 Liquid crystalline compound with negative dielectric anisotropy, liquid crystal composition using same, and liquid crystal display element
EP2631225A1 (en) * 2010-10-21 2013-08-28 JNC Corporation Cyclohexene-3,6-diyl compound, liquid crystal composition, and liquid crystal display element

Also Published As

Publication number Publication date
CN107619668A (en) 2018-01-23

Similar Documents

Publication Publication Date Title
KR101790751B1 (en) Polymer stable alignment type liquid crystal composition and use thereof
CN107267156B (en) Liquid crystal composition and application thereof
CN108659857B (en) Liquid crystal composition having positive dielectric anisotropy and display device thereof
CN107760317B (en) Liquid crystal composition containing cyclohexenyl liquid crystal compound and application thereof
CN107353908B (en) Negative dielectric anisotropy liquid crystal composition and application thereof
CN107189791B (en) Positive and negative mixed liquid crystal composition and application thereof
CN107446591A (en) A kind of liquid-crystal composition containing dibenzofurans class compound and its application
US10711194B2 (en) Liquid crystal composition and liquid crystal display element or liquid crystal display comprising same
CN107541221B (en) Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof
CN105670649A (en) Liquid crystal composition with high transmittance and application thereof
TW201920620A (en) Liquid crystal composition and liquid crystal display device
CN109423303B (en) Negative dielectric liquid crystal composition containing benzofuran compound and application thereof
CN107384442B (en) Negative dielectric anisotropy liquid crystal composition and application thereof
CN107619668B (en) Liquid crystal composition containing polyfluorobiphenyl liquid crystal compound and application thereof
CN110093166B (en) Liquid crystal composition containing self-aligned compound and application thereof
CN108659855B (en) Negative dielectric liquid crystal composition and application thereof
CN107345142B (en) Negative dielectric anisotropy liquid crystal composition containing naphthalene ring and application thereof
JPWO2019116904A1 (en) Liquid crystal composition and liquid crystal display device
CN107151557B (en) Liquid crystal composition containing cyclohexene compound and application
JPWO2019021838A1 (en) Liquid crystal composition and liquid crystal display device
TWI786218B (en) Liquid crystal composition and liquid crystal display element
CN107446592A (en) A kind of liquid-crystal composition containing cyclopropyl compounds and its application
KR101512173B1 (en) Polymerizable fluorine introduced reactive mesogen compound based on phenyl-thiophene core having improved solubility, preparation of thereof and polymerizable liquid crystal compositions containing the same
CN114525140A (en) Fast response negative liquid crystal composition and application thereof
CN111944540A (en) Acetylene negative monocrystal-containing liquid crystal composition and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant